Company intelligence / Profile preview
Esperante
Baarn, Utrecht, Netherlandsesperante.com ↗
- Ownership
- Private
- Employees
- ~900
- Development stage
- Other
01
Overview
As a corporate venture capital firm with deep roots in pharmaceutical development and diagnostics, Esperante has invested in over two dozen life science companies globally. Several portfolio assets have reached commercialization or advanced clinical stages. Notably:
- Cara’s Korsuva was FDA approved and launched.
- Three diagnostics investments have launched products in Europe.
- Four portfolio therapeutics/diagnostics firms are publicly listed.
- Therapeutic areas
- OncologyEndocrinologyWomen's HealthGastroenterologyOphthalmologyNeurologyInfectious Diseases
- Modalities
- Small moleculeBiologicPeptides
- Industry
- Investors
02
Drug pipeline
1 asset03
Partnerships
Co-invests with other VCs/life science investors on syndicate deals; specific partners not always disclosed but includes Scottish Enterprise & Thairm Bio via recent deals
Beyond the preview
Go deeper on Esperante.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Esperante.